No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension

Apr 03, 2022

Hyderabad (Telangana)[India], April 3 : Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is "no impact on efficacy and safety of the...

Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID-19, says Lancet

Nov 12, 2021

Hyderabad (Telangana) [India], November 12 : Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin.

WHO suspension for Covaxin supply only for UN agencies: Sources

Apr 04, 2022

New Delhi [India], April 4 : The World Health Organization's (WHO) suspension of supplies of Covaxin of the Bharat Biotech supply is not related...

Proven record for safety, says Bharat Biotech after Covaxin gets emergency usage nod for kids above 12 yrs

Dec 25, 2021

New Delhi [India], December 25 : Covaxin has a proven record for safety and efficacy from all the variants of COVID-19, said Bharat Biotech...

Phase 3 clinical trials of Covaxin shows 81 per cent efficacy, says Bharat Biotech

Mar 03, 2021

Hyderabad (Telangana) [India], March 3 : Bharat Biotech on Wednesday released results of Phase 3 clinical trials of its coronavirus vaccine Covaxin, with the...

'Covaxin shows overall 78 pc interim efficacy, 100 pc efficacy against severe COVID-19 disease'

Apr 21, 2021

Hyderabad (Telangana) [India], April 21 : Covaxin, India's indigenous vaccine against COVID-19 demonstrated "overall interim clinical efficacy" of 78 per cent and 100 per...